The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors

J Support Oncol. 2006 May;4(5):236-8.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Dermatologic Agents / therapeutic use
  • Dermatology
  • Doxycycline / therapeutic use
  • ErbB Receptors / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Exanthema / chemically induced
  • Exanthema / drug therapy
  • Eye Diseases / chemically induced
  • Female
  • Humans
  • Interprofessional Relations
  • Lung Neoplasms / drug therapy*
  • Medical Oncology
  • Middle Aged
  • Ophthalmology
  • Quinazolines / adverse effects*
  • Referral and Consultation*
  • Skin Diseases / chemically induced*
  • Skin Diseases / drug therapy
  • Tacrolimus / analogs & derivatives
  • Tacrolimus / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Dermatologic Agents
  • Quinazolines
  • pimecrolimus
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Doxycycline
  • Tacrolimus